ANXA2 and bladder transitional cell carcinoma: We observed a significant poor overall survival (OS) in BLCA patients with high AnxA2 mRNA expression [hazard ratio = 1.452; 95% confidence interval (CI) = 1.022−1.958, p = 0.0144; Figure 2A] compared to low AnxA2 mRNA expression.